Hormones and hormone antagonists

A stable inhibitor of FAS that leads to profound weight loss and feeding inhibition in both high-fat diet wild type obese and leptin-deficient ob/ob mice.

(&plusmn)12(13)-EpOME-d4 contains four deuterium atoms at the 9, 10, 12, and 13 positions. It is intended for use as an internal standard for the quantification of latanoprost by GC- or LC-MS.

(&plusmn)19(20)-DiHDPA is one of the major metabolites produced when DHA is incubated with NADPH-supplemented rat liver microsomes formed by the slow metabolism of DHA by monkey seminal vesicles.

Racemic version of a CYP450 metabolite of arachidonic acid.

An epoxide derivative of DHA that is generated by the action of CYP450 epoxygenases naturally occurring in plasma and brain and spinal cord tissues and is increased following dietary supplementation with &omega-3 fatty acids a substrate of

Racemic version of a CYP450 metabolite of arachidonic acid.

An internal standard for the quantification of latanoprost by GC- or LC-mass spectrometry (MS).

Cloprostenol is a synthetic PGF2&alpha analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15&beta-hydroxy enantiomer of (+)-cloprostenol.

Cloprostenol is a synthetic PGF2&alpha analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15&beta-hydroxy enantiomer of (+)-cloprostenol.

Cloprostenol is a synthetic PGF2&alpha analog and a potent FP receptor agonist. (+)-15-epi Cloprostenol is the 15(S), or 15&beta-hydroxy enantiomer of (+)-cloprostenol.

A minor impurity produced in the synthesis of (+)-cloprostenol 20-fold less active than (+)-cloprostenol in terminating pregnancy in the hamster.

A minor impurity produced in the synthesis of (+)-cloprostenol 20-fold less active than (+)-cloprostenol in terminating pregnancy in the hamster.